Home Tags Eleftherios Mylonakis

Tag: Eleftherios Mylonakis

A DRUG that may make a strain of “superbug” more vulnerable to treatment by antibiotics has been identified by an international research effort led by a team at Rhode Island Hospital. Above, Dr. Eleftherios Mylonakis, chief of infectious diseases at Rhode Island Hospital and The Miriam Hospital. / COURTESY LIFESPAN

Rhode Island Hospital researchers find drug to weaken ‘superbug’ cells

PROVIDENCE – A drug that may make a strain of “superbug” more vulnerable to treatment by antibiotics has been identified by an international research...
THE MIRIAM HOSPITAL has received a $9.4 million grant from the National Institutes of Health to establish the Center for Antimicrobial Resistance and Therapeutic Discovery to research "superbugs" and to look for potential new drugs. / COURTESY LIFESPAN

The Miriam Hospital receives $9.4M grant to study antibiotic resistance

PROVIDENCE – The Miriam Hospital has received a five-year, $9.4 million grant from the National Institutes of Health to create an NIH Center for...
- Featured Event -

Latest News